SCHEDULE 13G/A: AWM Investment Company Discloses 4.8% Stake in NeuroOne Medical Technologies Corp
Beneficial Ownership Report
AWM Investment Company, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 4.8% in NeuroOne Medical Technologies Corp, totaling 2,354,167 shares.
Summary
- AWM Investment Company, Inc. (AWM) filed Amendment No. 4 to Schedule 13G regarding its beneficial ownership in NEUROONE MEDICAL TECHNOLOGIES Corp.
- AWM, acting as an investment adviser to Special Situations Private Equity Fund, L.P. (SSPE) and Special Situations Life Sciences Fund, L.P. (SSLS), reported an aggregate beneficial ownership of 2,354,167 shares of Common Stock.
- This beneficial ownership represents 4.8% of the issuer's class of Common Stock.
- AWM holds sole voting and dispositive power over all 2,354,167 beneficially owned shares.
- The reported beneficial ownership includes 1,166,667 shares of Common Stock and warrants to purchase an additional 1,000,000 shares (416,667 from SSPE and 583,333 from SSLS).
- The exercise of these warrants is subject to a limitation, ensuring that the total number of Common Shares beneficially owned does not exceed 9.99% of the outstanding shares.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or outlook.
Positives
- AWM Investment Company, Inc., an investment adviser, holds a significant beneficial ownership stake of 4.8% in NeuroOne Medical Technologies Corp, which may be interpreted as a signal of investor confidence.
Risks
- Warrants held by AWM Investment Company, Inc. and its advised funds (SSPE and SSLS) are subject to an exercise limitation, preventing the total beneficial ownership from exceeding 9.99% of the outstanding shares, which could limit their ability to increase their stake rapidly through warrant exercise.
Future Outlook
NA
Industry Context
This filing is a disclosure of beneficial ownership by an investment adviser in a specific company and does not provide information related to broader industry trends or competitive landscape.
Related Party Transactions
- The filing details the relationship between AWM Investment Company, Inc. as the investment adviser and its advised funds, Special Situations Private Equity Fund, L.P. and Special Situations Life Sciences Fund, L.P., which hold the beneficial ownership.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by AWM Investment Company, Inc. may be viewed as a vote of confidence in NeuroOne Medical Technologies Corp, potentially influencing investor perception positively.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event requiring the filing of this statement (reporting period end date). |
| 05/09/2025 | Date of signature for the Schedule 13G Amendment No. 4. |
Keywords
SEC filing, Schedule 13G, beneficial ownership, investment adviser, NeuroOne Medical Technologies Corp, Common Stock, warrants, institutional ownership, equity stake, AWM Investment Company
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.